Description

PharmaQo Winstrol 10 delivers 10 mg Stanozolol per oral tablet, packaged in 100-tablet units for research use. Stanozolol is studied for its anabolic properties, impact on lean tissue preservation, nitrogen balance, and potential applications in investigational bone and muscle models.

Known for its non-aromatizing nature and strong anabolic-to-androgenic ratio, Stanozolol is frequently included in studies focusing on tissue retention and metabolic research.

Product Details:
Active Ingredient:

• Stanozolol (Winstrol)

Concentration: 10 mg per tablet

Form: Oral tablets

Packaging: 100 tablets per pack

Pharmacokinetics:
Stanozolol has an oral half-life of ~9 hours, requiring daily or divided dosing in research protocols.

Usage Recommendations:

• Indications (Research Context): Investigational use in lean tissue retention studies, metabolic models, nitrogen balance trials (not approved for human use)

• Typical Dosage (Research Use): 20–50 mg per day, depending on study design

• Monitoring: Liver enzymes, lipid profile, cardiovascular health, androgenic markers

• Cycle/Duration: 4–8 weeks, per research protocol

Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical risks. Always comply with local research laws and ethical standards.